XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Current assets      
Cash and cash equivalents $ 47,455 $ 57,445  
Marketable securities (Notes 4 and 15) 101,154 133,044  
Trade and other receivables, net of allowance for credit losses of $223 and $223, as of September 30, 2024 and December 31, 2023, respectively 4,914 816  
Inventories (Note 5) 35,910 38,868  
Prepaid expenses and other current assets 4,490 2,522  
Total current assets 193,923 232,695  
Mineral properties, net (Note 6) 124,856 119,581  
Property, plant and equipment, net (Note 6) 43,548 26,123  
Inventories (Note 5) 0 1,852  
Operating lease right of use asset 1,079 1,219  
Investments (Note 7) 12,130 1,356  
Intellectual property (Note 3) 4,821 0  
Other long-term receivables 763 1,534  
Restricted cash (Note 8) 19,284 17,579  
Total assets 400,404 401,939  
Current liabilities      
Accounts payable and accrued liabilities (Note 13) 8,213 10,161  
Contingent consideration (Note 3) 1,727   $ 0
Deferred revenue 600   0
Operating lease liability 228 199  
Total current liabilities 10,768 10,360  
Operating lease liability 946 1,120  
Asset retirement obligations (Note 8) 12,003 10,922  
Deferred revenue 0 332  
Total liabilities 23,717 22,734  
Equity      
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 164,678,756 and 162,659,155 as of September 30, 2024 and December 31, 2023, respectively 745,792 733,450  
Accumulated deficit (371,097) (356,258)  
Accumulated other comprehensive loss (1,946) (1,946)  
Total shareholders' equity 372,749 375,246  
Non-controlling interests 3,938 3,959  
Total equity 376,687 379,205 $ 383,328
Total liabilities and equity 400,404 401,939  
Commitments and contingencies (Note 14)